A novel real-time RT-PCR assay for quantification of OTT-MAI, fusion transcripts allows minimal residual disease (MRD) follow-up and suggest that t(1;22) may escape conventional cytogenetic detection in infant acute megakaryoblastic leukemia (M7)

EXPERIMENTAL HEMATOLOGY(2003)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要